Policy Watch: Ohio House Bill 462 updated school health statutes to recognize any FDA-approved emergency treatment option for severe allergic reactions, including needle-free delivery methods. The change broadens state law beyond a single device type and provides flexibility for future FDA-approved options. #PolicyWatch #AllergyAwareness

Health literacy extends beyond the patient. In severe allergy care, family members, caregivers, teachers, coaches and coworkers may play a role in responding to an allergic emergency. This #HealthLiteracyMonth, consider reviewing your allergy action plan with someone who may need to use it. Learn more: aafa.org/allergies/allergy-t… #AllergyAwareness

Our school community program provides needle-free emergency treatment to K-12 schools at no cost. Heading into the new school year, it has now been used in 251 reported emergencies, each one a severe allergic reaction at school. The program now reaches more than 13,000 schools. #BackToSchool #AllergyAwareness

Join us at two upcoming investor conferences this month. President and CEO Donn Casale will attend investor meetings at the Wells Fargo Healthcare Conference in Boston and participate in a fireside chat and investor meetings at the Cantor Global Healthcare Conference in New York. We look forward to discussing our continued work to transform care for patients at risk of severe allergic reactions. Learn more: ir.ars-pharma.com/news-relea… $SPRY #AllergyAwareness #WellsFargoHealthcare #Cantor

ARS Pharma has appointed Meg Smith as Chief Commercial Officer. Meg joins ARS Pharma with more than 25 years of commercial leadership experience in the biopharmaceutical industry, including extensive expertise in building U.S. commercial organizations, spearheading successful product launches, and driving long-term growth strategies. In her new role, she will lead ARS efforts to ensure patients, caregivers, and prescribers are equipped to respond with our emergency treatment for severe allergic reactions when seconds matter. $SPRY #Leadership #AllergyAwareness

A new school year brings renewed focus on readiness for severe allergic reactions. Our school community program supports eligible K-12 schools in more than 30 states with severe allergy treatment at no cost. #BackToSchool

Back-to-school planning goes beyond academics and extracurricular activities. For millions of families, it also includes preparing for severe allergic reactions in school settings. Check out this checklist: bit.ly/3TV2sMU

School is back in session across the country, filling up the calendar and bringing new routines and environments for every child. This also includes preparing your children in case of a severe allergic reaction. Review this checklist as you and your family finalize your back-to-school plans: bit.ly/4fQHGql

Heading to college with a food allergy means a new campus and a new emergency response system. FAACT has a practical blog on who to call and what to do before a reaction happens on campus. Worth a read as the semester begins: foodallergyawareness.org/blo… #FoodAllergy #BackToSchool #AllergyAwareness

ARS Pharmaceuticals has released its second quarter 2026 financial results and business update. Read the full release: bit.ly/3TVMouq $SPRY #Earnings #Investors

Two years ago this month, the FDA approved a new treatment option for Type 1 allergic reactions, including anaphylaxis. Our focus since then hasn’t changed: transforming severe allergy care and the communities we serve. #AllergyAwareness

A significant share of severe allergic reactions in schools occur in students with no known allergy, most of them in classrooms, not the nurse's office. The FAMS Expert Recommendations (FARE, with CDC and AAP) point to whole-building readiness. foodallergy.org/resources/fo… #AllergyAwareness #SchoolHealth

ARS Pharmaceuticals will soon report its second quarter 2026 financial results and business highlights. Read more: bit.ly/4pWgIRj $SPRY #Earnings #Investors

When a severe allergic reaction happens at school, every second counts. That’s where stock epinephrine comes in—a supply kept on hand for any student or staff member experiencing anaphylaxis. As states expand policies around emergency treatment and the products schools can keep on site, stock epinephrine programs are becoming an essential part of school readiness. Need a refresher? See below for a quick primer and be sure to check your state’s specific requirements. #SchoolNursing #AllergyAwareness

Policy Watch: Alabama widened emergency allergy access in 2026. A new law allows restaurants, camps, daycares, colleges, workplaces and sports arenas to keep FDA-approved epinephrine delivery products on hand, and schools can follow later this year. #PolicyWatch #AllergyAwareness

Since FDA approval in August 2024, our product for severe allergic reactions has reached regulatory approval across the major developed pharmaceutical markets, covering more than 30 countries. For the latest news & regulatory milestones: bit.ly/4aaOQT2 #SevereAllergies

Back-to-school planning for severe allergy preparedness starts earlier than most people realize. By the time the first bell rings in August, school nurses and district administrators have already spent the summer auditing stock supplies, training staff, and reviewing protocols. Our school community program is working alongside eligible districts in 25+ states this summer to make sure schools have the emergency allergy treatment and training they need before the first day — at no cost. #BackToSchool #SchoolHealth #AllergyCare #AnaphylaxisPreparedness

We’re at #NASN2026 as a conference sponsor. Join our session on July 1 for a conversation about what readiness for severe allergic reactions really looks like in schools, featuring allergist Dr. Susan Laubach. @schoolnurses #AllergyAwareness

Policy Watch: Virginia’s SB 183 takes effect July 1, 2026. Restaurants in the Commonwealth will be required to clearly mark any delivery or carryout order modified due to a customer-reported food allergy. The Virginia Board of Health will develop standardized labeling. For the millions of Americans living with food allergies, takeout has long carried a particular kind of uncertainty. SB 183 closes that gap at the point where it matters most: the package itself. #FoodAllergy #AllergyAwareness

This week is #WorldAllergyWeek2026, led by @worldallergy. This year's campaign centers on a clear message: allergy care is essential care. ARS Pharma joins the global allergy and immunology community in recognizing the week and the continued work to improve care for patients at risk of severe allergic reactions.